{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:53:05Z","timestamp":1775807585591,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The Pharmacy Service of the Infanta Leonor University Hospital acquires, compounds, distributes and dispenses more than 3000\u00a0L of methadone oral solution to Drug Addiction Patients Centers per year. Our purpose is to develop and validate an improved high performance liquid chromatography (HPLC) method to quantify methadone hydrochloride in a new oral solution with methylhydroxybenzoate (methylparaben) and propylhydroxybenzoate (propylparaben) to be implemented in physicochemical stability studies that allow to provide more information and even to increase the beyond-use date.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A HPLC-Agilent<jats:sup>\u00ae<\/jats:sup> 1100 equipment, comprising a quaternary pump and an ultraviolet diode-array-detector (DAD) was used. An analytical method development and validation was completed. The curve was constructed from methadone working concentrations of 75\u2013125% (7.5, 9.0, 10.0, 11.0 and 12.5\u00a0mg\/mL) to assess the linear relationship between the concentration of the analyte and the obtained areas. Precision and accuracy were calculated. Detection and quantification limit (LD, LQ) were estimated using the EURACHEM method. Forced-degradation studies were also performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Chromatographic conditions were: flow rate 1.6\u00a0mL\/min; mobile phase 55% acetonitrile and 45% sodium phosphate 25\u00a0mM (pH\u2009=\u200910); injection volume was 5 \u00b5L. The column was a Waters-XTerra\u2122 RP18, maintained at 40\u00a0\u00b0C. DAD was \u03bb\u2009=\u2009254\u00a0nm. Retention times for methadone, methylparaben and propylparaben were 4.34, 0.70 and 0.88\u00a0min respectively.<\/jats:p>\n                <jats:p>The method was linear (y\u2009=\u2009284.3x\u2009\u2212\u200997.8, r\u2009=\u20090.996). Instrumental precision was 0.33% for standards (n\u2009=\u200910); intra-assay precision 0.53% (n\u2009=\u20096) and inter-assay precision 1.95% (n\u2009=\u200912). The relative standard deviation percentage for accuracy was 1.28%. The recovery percentage was 101.5\u2009\u00b1\u20091.5%. LQ and LD were 2.18\u00a0\u00b5g\/mL and 2.0\u00a0\u00b5g\/mL respectively. The most destabilizing conditions were oxidizing and alkaline. The chromatograms confirmed no interference with the methadone signal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The HPLC method has proved to be valid and reproducible for methadone quantification in a new oral solution with methylparaben and propylparaben. This assay is a rapid, simple and reliable technique that can be used in daily analysis and physicochemical stability studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13065-022-00827-9","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T12:09:43Z","timestamp":1652530183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of a HPLC-UV method for methadone hydrochloride quantification in a new oral solution with preservatives to be implemented in physicochemical stability studies"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-8054","authenticated-orcid":false,"given":"Elena Alba","family":"\u00c1lvaro-Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-2051","authenticated-orcid":false,"given":"M\u00aa Paz","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4188-7624","authenticated-orcid":false,"given":"Ismael","family":"Escobar-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6351-3856","authenticated-orcid":false,"given":"Antonio","family":"Aguilar-Ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"key":"827_CR1","unstructured":"Resoluci\u00f3n del director general de coordinaci\u00f3n de la asistencia sanitaria por la que se encomienda al Hospital Universitario Infanta Leonor las tareas de suministro diario de metadona a los centros de atenci\u00f3n integral a drogodependientes de la Subdirecci\u00f3n General de Asistencia en Adicciones del Servicio Madrile\u00f1o de Salud. Direcci\u00f3n General de Coordinaci\u00f3n de la Asistencia Sanitaria, no 189\/2018, (27 de febrero de 2018)."},{"key":"827_CR2","unstructured":"Formulario Nacional. 3a Ed. 2020.https:\/\/www.aemps.gob.es\/laAEMPS\/docs\/formulario-nacional.pdf?x59481&x60265"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7399\/fh.11384","volume":"44","author":"EA \u00c1lvaro-Alonso","year":"2020","unstructured":"\u00c1lvaro-Alonso EA, Tejedor-Prado P, Aguilar-Ros A, et al. Centralization of the methadone maintenance plan in a hospital pharmacy department in the Community of Madrid. Farm Hosp. 2020;44:185\u201391. https:\/\/doi.org\/10.7399\/fh.11384.","journal-title":"Farm Hosp"},{"key":"827_CR4","unstructured":"Metadona, hidrocloruro de (01\/2008, 0408). Real Farmacopea Espa\u00f1ola en internet. 5a ed. 2015.https:\/\/extranet.boe.es\/farmacopea\/doc.php?id=0408"},{"key":"827_CR5","unstructured":"The United States Pharmacopeia: USP\u2013NF 2021, 2021; (3)."},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/jps.2600661224","volume":"66","author":"TH Beasley","year":"1977","unstructured":"Beasley TH, Ziegler HW. High-performance liquid chromatographic analysis of methadone hydrochloride oral solution. J Pharm Sci. 1977;66:1749\u201351. https:\/\/doi.org\/10.1002\/jps.2600661224.","journal-title":"J Pharm Sci"},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/s0021-9673(01)85255-9","volume":"161","author":"J Hsieh","year":"1978","unstructured":"Hsieh J, Ma J, O\u2019donell J, et al. High-performance liquid-chromatographic analysis of methadone in sustained-release formulations. J Chromatogr. 1978;161:366\u201370. https:\/\/doi.org\/10.1016\/s0021-9673(01)85255-9.","journal-title":"J Chromatogr"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/jps.2600720613","volume":"72","author":"H Derendorf","year":"1983","unstructured":"Derendorf H, Garrett ER. High-performance liquid chromatographic assay of methadone, phencyclidine, and metabolites by postcolumn ion-pair extraction and on-line fluorescent detection of the counterion with applications. J Pharm Sci. 1983;72:630\u20135. https:\/\/doi.org\/10.1002\/jps.2600720613.","journal-title":"J Pharm Sci"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0021-9673(01)81953-1","volume":"329","author":"P Adams","year":"1985","unstructured":"Adams P, Haines-nutt R. High-performance liquid-chromatographic analysis of methadone hydrochloride in pharmaceuticals. J Chromatogr. 1985;329:438\u201340. https:\/\/doi.org\/10.1016\/S0021-9673(01)81953-1.","journal-title":"J Chromatogr"},{"key":"827_CR10","first-page":"178","volume":"64","author":"HJ Helmlin","year":"1989","unstructured":"Helmlin HJ, Bqurquin D, De Bernardini M, et al. Determination of methadone in pharmaceutical preparations using high-performance liquid chromatography with photodiode array detection. Pharm Acta Helv. 1989;64:178\u201382.","journal-title":"Pharm Acta Helv"},{"key":"827_CR11","first-page":"249","volume":"22","author":"D Soy","year":"1998","unstructured":"Soy D, Roca M, Deulofeu R, et al. Stability of 0.1% and 0.5% oral methadone clorhydrate solutions in saline. Farm Hosp. 1998;22:249\u201351.","journal-title":"Farm Hosp"},{"key":"827_CR12","first-page":"141","volume":"73","author":"MM Friciu","year":"2020","unstructured":"Friciu MM, Alarie H, Beauchemin M, et al. Stability of methadone hydrochloride for injection in saline solution. Can J Hosp Pharm. 2020;73:141\u20134.","journal-title":"Can J Hosp Pharm"},{"key":"827_CR13","first-page":"1252","volume":"48","author":"G Lauriault","year":"1991","unstructured":"Lauriault G, Lebelle M, Lodge B, et al. Stability of methadone in 4 vehicles for oral-administration. Am J Hosp Pharm. 1991;48:1252\u20136.","journal-title":"Am J Hosp Pharm"},{"key":"827_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3109\/10837450.2015.1055765","volume":"21","author":"N Provenza","year":"2016","unstructured":"Provenza N, Calpena AC, Mallandrich M, et al. Design of pediatric oral formulations with a low proportion of methadone or phenobarbital for the treatment of neonatal abstinence syndrome. Pharm Dev Technol. 2016;21:755\u201362. https:\/\/doi.org\/10.3109\/10837450.2015.1055765.","journal-title":"Pharm Dev Technol"},{"key":"827_CR15","first-page":"159","volume":"19","author":"MS Ching","year":"1989","unstructured":"Ching MS, Stead ChK, Shilson AD. Stability of methadone mixture with methyl hydroxybenzoate as a preservative. Aust J Hosp Pharm. 1989;19:159\u201361.","journal-title":"Aust J Hosp Pharm"},{"key":"827_CR16","first-page":"1007","volume":"35","author":"E Miguez-Diez","year":"2013","unstructured":"Miguez-Diez E, Pitarch-Sierra A, Modamio P, et al. HPLC-UV method development and validation for quantitative determination of methadone in human plasma. Int J Clin Phar. 2013;35:1007\u20131007.","journal-title":"Int J Clin Phar"},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.talanta.2015.11.044","volume":"149","author":"R George","year":"2016","unstructured":"George R, Lobb M, Haywood A, et al. Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. Talanta. 2016;149:142\u20138. https:\/\/doi.org\/10.1016\/j.talanta.2015.11.044.","journal-title":"Talanta"},{"key":"827_CR18","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1021\/ac061095b","volume":"78","author":"S Castiglioni","year":"2006","unstructured":"Castiglioni S, Zuccato E, Crisci E, et al. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography\u2212tandem mass spectrometry. Anal Chem. 2006;78:8421\u20139. https:\/\/doi.org\/10.1021\/ac061095b.","journal-title":"Anal Chem"},{"key":"827_CR19","doi-asserted-by":"publisher","first-page":"7901","DOI":"10.1016\/j.chroma.2011.08.092","volume":"1218","author":"DR Baker","year":"2011","unstructured":"Baker DR, Kasprzyk-Hordern B. Multi-residue determination of the sorption of illicit drugs and pharmaceuticals to wastewater suspended particulate matter using pressurised liquid extraction, solid phase extraction and liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A. 2011;1218:7901\u201313. https:\/\/doi.org\/10.1016\/j.chroma.2011.08.092.","journal-title":"J Chromatogr A"},{"key":"827_CR20","doi-asserted-by":"publisher","unstructured":"Foppe KS, Subedi B. Analysis of Illicit Drugs in Wastewater Using High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry (HPLC-ESI-MS\/MS). In: Musah RA, ed. Analysis of Drugs of Abuse. New York: Springer New York 2018. 183\u201391. Doi:https:\/\/doi.org\/10.1007\/978-1-4939-8579-1_16","DOI":"10.1007\/978-1-4939-8579-1_16"},{"key":"827_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.chroma.2018.05.019","volume":"1560","author":"G Musile","year":"2018","unstructured":"Musile G, Cenci L, Piletska E, et al. Development of an in-house mixed-mode solid-phase extraction for the determination of 16 basic drugs in urine by High Performance Liquid Chromatography-Ion Trap Mass Spectrometry. J Chromatogr A. 2018;1560:10\u20138. https:\/\/doi.org\/10.1016\/j.chroma.2018.05.019.","journal-title":"J Chromatogr A"},{"key":"827_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1248\/bpb.b17-00691","volume":"41","author":"H Kokubun","year":"2018","unstructured":"Kokubun H, Takigawa C, Miyano K, et al. A novel method for determination of methadone in the serum by high-performance liquid chromatography with electrochemical detection. Biol Pharm Bull. 2018;41:649\u201351. https:\/\/doi.org\/10.1248\/bpb.b17-00691.","journal-title":"Biol Pharm Bull"},{"key":"827_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/ajhp\/48.3.515","volume":"48","author":"DD Denson","year":"1991","unstructured":"Denson DD, Crews JC, Grummich KW, et al. Stability of methadone hydrochloride in 0.9% sodium chloride injection in single-dose plastic containers. Am J Health Syst Pharmacy. 1991;48:515\u20137. https:\/\/doi.org\/10.1093\/ajhp\/48.3.515.","journal-title":"Am J Health Syst Pharmacy"},{"key":"827_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00007691-198603000-00016","volume":"8","author":"DE Coyle","year":"1986","unstructured":"Coyle DE, Denson DD. Simultaneous measurement of bupivacaine, etidocaine, lidocaine, meperidine, mepivacaine, and methadone. Ther Drug Monit. 1986;8:98\u2013101. https:\/\/doi.org\/10.1097\/00007691-198603000-00016.","journal-title":"Ther Drug Monit"},{"key":"827_CR25","unstructured":"European Medicines Agency. ICH Topic Q2 (R1). Validation of Analytical Procedures: Text and Methodology. 2006.https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-2-r1-validation-analytical-procedures-text-methodology-step-5_en.pdf (Accessed 2 May 2020)."},{"key":"827_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s1570-0232(02)00244-1","volume":"774","author":"AM Almeida","year":"2002","unstructured":"Almeida AM, Castel-Branco MM, Falc\u00e3o AC. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;774:215\u201322. https:\/\/doi.org\/10.1016\/s1570-0232(02)00244-1.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"827_CR27","unstructured":"Eurachem, Guidance Document No. WGD 2, Accreditation for Chemical Laboratories: Guidance on the Interpretation of the EN45000 Series of Standards and ISO\/IEC, Guide 25, 1993. https:\/\/www.eurachem.org\/images\/stories\/Guides\/pdf\/Eurachem_CITAC_QAC_2016_EN.pdf"},{"key":"827_CR28","unstructured":"European Medicines Agency. Guideline on Stability Testing: Stability Testing of Existing Active Substances and Related Finished Products. 2007.https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-stability-testing-stability-testing-existing-active-substances-related-finished-products_en.pdf (Accessed 2 May 2020)."},{"key":"827_CR29","unstructured":"European Medicines Agency (EMA), Committee for Medicinal Products for Human Use. Guideline on bioanalytical method validation. 2011.https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf (Accessed 8 Mar 2020)."}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-022-00827-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-022-00827-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-022-00827-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T12:11:51Z","timestamp":1652530311000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-022-00827-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s13065-022-00827-9","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"29 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants. This study does not involve animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}